Abstract
Optimal multidisciplinary care of the lung cancer patient at all stages should encompass integration of the key relevant medical specialties, including not only medical, surgical, and radiation oncology, but also pulmonology, interventional and diagnostic radiology, pathology, palliative care, and supportive services such as physical therapy, case management, smoking cessation, and nutrition. Multidisciplinary management starts at staging and tissue diagnosis with pathologic and molecular phenotyping, extends through selection of a treatment modality or modalities, management of treatment and cancer-related symptoms, and to survivorship and end-of-life care. Well-integrated multidisciplinary care may reduce treatment delays, improve cancer-specific outcomes, and enhance quality of life. We address key topics and areas of ongoing investigation in multidisciplinary decision making at each stage of the lung cancer treatment course for early-stage, locally advanced, and metastatic lung cancer patients.
| Original language | English (US) |
|---|---|
| Title of host publication | Cancer Treatment and Research |
| Publisher | Kluwer Academic Publishers |
| Pages | 285-300 |
| Number of pages | 16 |
| Volume | 170 |
| DOIs | |
| State | Published - 2016 |
Publication series
| Name | Cancer Treatment and Research |
|---|---|
| Volume | 170 |
| ISSN (Print) | 09273042 |
Fingerprint
Keywords
- Integrated care
- Multidisciplinary care
- Multimodality treatment
- Non-small cell lung cancer
ASJC Scopus subject areas
- Medicine(all)
- Oncology
- Cancer Research
Cite this
Multidisciplinary care. / Daly, Megan E; Riess, Jonathan.
Cancer Treatment and Research. Vol. 170 Kluwer Academic Publishers, 2016. p. 285-300 (Cancer Treatment and Research; Vol. 170).Research output: Chapter in Book/Report/Conference proceeding › Chapter
}
TY - CHAP
T1 - Multidisciplinary care
AU - Daly, Megan E
AU - Riess, Jonathan
PY - 2016
Y1 - 2016
N2 - Optimal multidisciplinary care of the lung cancer patient at all stages should encompass integration of the key relevant medical specialties, including not only medical, surgical, and radiation oncology, but also pulmonology, interventional and diagnostic radiology, pathology, palliative care, and supportive services such as physical therapy, case management, smoking cessation, and nutrition. Multidisciplinary management starts at staging and tissue diagnosis with pathologic and molecular phenotyping, extends through selection of a treatment modality or modalities, management of treatment and cancer-related symptoms, and to survivorship and end-of-life care. Well-integrated multidisciplinary care may reduce treatment delays, improve cancer-specific outcomes, and enhance quality of life. We address key topics and areas of ongoing investigation in multidisciplinary decision making at each stage of the lung cancer treatment course for early-stage, locally advanced, and metastatic lung cancer patients.
AB - Optimal multidisciplinary care of the lung cancer patient at all stages should encompass integration of the key relevant medical specialties, including not only medical, surgical, and radiation oncology, but also pulmonology, interventional and diagnostic radiology, pathology, palliative care, and supportive services such as physical therapy, case management, smoking cessation, and nutrition. Multidisciplinary management starts at staging and tissue diagnosis with pathologic and molecular phenotyping, extends through selection of a treatment modality or modalities, management of treatment and cancer-related symptoms, and to survivorship and end-of-life care. Well-integrated multidisciplinary care may reduce treatment delays, improve cancer-specific outcomes, and enhance quality of life. We address key topics and areas of ongoing investigation in multidisciplinary decision making at each stage of the lung cancer treatment course for early-stage, locally advanced, and metastatic lung cancer patients.
KW - Integrated care
KW - Multidisciplinary care
KW - Multimodality treatment
KW - Non-small cell lung cancer
UR - http://www.scopus.com/inward/record.url?scp=84983739020&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84983739020&partnerID=8YFLogxK
U2 - 10.1007/978-3-319-40389-2_13
DO - 10.1007/978-3-319-40389-2_13
M3 - Chapter
C2 - 27535399
AN - SCOPUS:84983739020
VL - 170
T3 - Cancer Treatment and Research
SP - 285
EP - 300
BT - Cancer Treatment and Research
PB - Kluwer Academic Publishers
ER -